CD8 T-cell (T CD8؉)
Immunodominance is a central feature of CD8
ϩ T-cell (T CD8ϩ ) responses to viruses, bacteria, tumors, and minor H antigens. Of the many thousands of peptides present in such complex antigens, relatively few are recognized by responding T CD8ϩ , and responses to these few peptides can be ordered based on the numbers of responding T CD8ϩ into a relatively stable hierarchy. Despite its importance to understanding immune responses and designing vaccines, immunodominance is poorly understood at the mechanistic level. It is clear that immunodominance is not simply explained by the numbers of peptide complexes generated by antigen-presenting cells (APCs), the affinities of peptides for class I molecules, or the affinities of T-cell receptors for peptide-class I complexes, though each of these parameters contributes to the phenomenon (45) .
Recent technical advances in quantitating T CD8ϩ responses have facilitated detailed mechanistic dissection of immunodominance. It is now possible to accurately enumerate T CD8ϩ responses to individual peptide determinants of complex antigens ex vivo using intracellular cytokine staining (ICS), enzyme-linked immunospot assay, or major histocompatibility complex (MHC)-peptide tetramer-based techniques (27) . These methods enable the definition of immunodominance hierarchies in response to complex antigens, which provides a background for exploration of underlying mechanisms. Determinants eliciting the most vigorous responses are termed immunodominant determinants (IDDs), with other determinants referred to as subdominant determinants (SDDs) (35) .
In many respects, the best-characterized system for studying immunodominance in T CD8ϩ responses is the infection of BALB/c or C57/BL6 mice with influenza virus (IV). Previous findings in this system have demonstrated that multiple factors contribute to immunodominance hierarchies (10, 14) . A major factor contributing to the ascendance of IDDs over SDDs is the suppression of SDD-specific T CD8ϩ by IDD-specific T CD8ϩ , a phenomenon termed immunodomination. Based on findings using mice immunized with multiple synthetic peptide determinants, Sandberg et al. suggested that T CD8ϩ compete at the level of APCs for activation (33) , an idea is supported by the recent findings of Kedl et al. (22) . One potential mechanism of competition is that the initial responding (immunodominant) T CD8ϩ lyse APCs, preventing activation of laterarriving (subdominant) clones. Indeed, Loyer et al. found that T CD8ϩ specific for minor H antigens can destroy adoptively transferred APCs by a perforin-dependent process (25) , and destruction of dendritic cells by tumor-or virus-specific T CD8ϩ has been reported (31) .
An additional possible contributing factor for immunodominance hierarchies is the requirement for assistance provided by T CD4ϩ . T CD4ϩ aid T CD8ϩ responses in several ways, including local secretion of cytokines and modification of APCs to enhance their T CD8ϩ -activating capacity (5, 15, 30, 34, 44) . Such modifications may include enhanced expression of B7, whose interaction with naïve T CD8ϩ strongly favors activation (8, 26, 32) . An important issue is the role costimulation plays in establishing immunodominance hierarchies. Does it assist, hinder, or not greatly affect the immunodominance hierarchy?
Another factor that can influence immunodominance hierarchies is the presence of responses to new determinants restricted by other class I molecules. In humans, for example, responses to determinants can be rather unpredictable among individuals (7) . Given that each individual has a unique history of exposure to foreign antigens, it is difficult to sort out the contributions of nature (i.e., genotype) versus nurture (i.e., prior antigenic experience). Obviously, this question is much more easily addressed using inbred mice maintained under controlled conditions.
To define the importance of these potential factors in establishing immunodominance hierarchies, we studied influenza virus specific-T CD8ϩ responses in mice deficient in perforin or T CD4ϩ or following interference with B7 (CD80)-mediated signaling. Our findings support the idea that none of these factors plays an essential role in establishing the immunodominance hierarchy in T CD8ϩ responses.
MATERIALS AND METHODS
Mice, virus, T CD8؉ priming in vivo, antibody blocking, and ICS assay.
, and BALB/c ϫ C57/BL6 F 1 (CB6 F 1 , H-2 b ϫ H-2 b ) mice were purchased from Taconic (Germantown, N.Y.). BALB/c perforin Ϫ/Ϫ mice were provided by John Harty (43) . Eight-to 10-week-old female mice were primed by intraperitoneal (i.p.) injection with 600 hemagglutinating units of influenza virus A/Puerto Rico/8/34 (PR8). For blocking experiments, antibodies and recombinant CTLA-4.Fc at 150 to ϳ200 g/mouse were injected i.p. 1 day before, 1 day after, and on the day of PR8 priming. Primed splenic cells and peritoneal cells were prepared at various days after priming. T CD8ϩ responses were quantitated by ICS for gamma interferon (IFN-␥) accumulation following peptide stimulation (19) as described previously (10) . Briefly, splenocytes or peritoneal exudate cells were stained first with Cychrome-labeled anti-CD8␣ (BD-Pharmingen, San Diego, Calif.). Cells were then washed and fixed with 1% paraformaldehyde and further stained in the presence of 0.2% saponin with fluorescein isothiocyanate-labeled anti-IFN-␥ (BD-Pharmingen). Cells were analyzed by flow cytometry.
Peptides, monoclonal antibodies, and other reagents. All peptides were synthesized, purified by high-performance liquid chromatography, and analyzed by mass spectrometry by or under the supervision of the Biologic Resource Branch, National Institute of Allergy and Infectious Diseases (Rockville, Md.). All peptides were dissolved in dimethyl sulfoxide at a 1 mM concentration as stock solutions and kept at Ϫ30°C. Anti-CTLA-4 (UC10-4F10-11 (42) , anti-CD4 (GK1.4) monoclonal antibody (MAb) ascites and anti-CD8␣ (53.6) MAb were purified from ascites produced in SCID mice and purchased from Charles River Laboratories (Wilmington, Mass.). The production of recombinant CTLA-4.Fc and its mutant form MutCTLA-4.Fc, which lacks the binding site for B7 molecules, has been described (21) .
RESULTS
Immunodominance hierarchies in normal mice. Table 1 lists a number of defined IV peptides that are recognized by virusspecific T CD8ϩ in B6 and BALB/c mice (2, 3, 4, 10, 17, 40) . In addition, we described here a novel D d -restricted peptide from PB2, PB2 289-297 , that we identified using the peptide motif prediction algorithm of Rammensee and colleagues (29) . The synthetic version of this peptide sensitizes target cells for lysis by PB2-specific T CD8ϩ in the picomolar range and coelutes with the naturally processed peptide by high-performance liquid chromatography (W. Chen, unpublished observations).
We have previously described the primary responses to these determinants in B6 and BALB/c mice following i.p. infection with PR8 (10, 12) . In Fig. 1 and 2 we replot the data sets originally described in these references as absolute numbers of responding cells. These data define a baseline for the experimental manipulations that follow. Importantly, the variation in responses between individual mice in a given experiment is within the variation that we observe between individuals in different experiments. This enabled us to limit experiments FIG. 1. Immunodominance hierarchy following i.p. infection with PR8 in B6 and B6 knockout mice. Splenic and peritoneal cells were prepared at the indicated times after PR8 infection, and responses to individual determinants were assessed by ICS using a panel of H-2 brestricted peptides. All responses were normalized by subtracting the background obtained with APCs not exposed to peptides. These percentages were used to calculate the numbers of antigen-specific cells among all T CD8ϩ recovered from spleens (left panels) or peritoneal exudates (right panels). We used different scales for splenic and peritoneal responses due to differences in total cell numbers. CD4 Ϫ/Ϫ animals and I-A bϪ/Ϫ animals were assayed on the same day. Each point represents the average value for three individual animals. In a separate experiment, perforin Ϫ/Ϫ (pf Ϫ/Ϫ ) mice exhibited a day 7 response similar to that shown. Data from wild-type mice are replotted from reference 12; we observed similar responses on day 7 in 10 individual experiments. Ag, antigen. with knockout mice to a manageable size by not always including wild-type mice as controls. Another finding supports the validity of this approach: for any given mouse the relative positions of determinants within the immunodominance hierarchy are independent of the absolute magnitude of the response. To recapitulate our previous observations, we collected T CD8ϩ from spleen and peritoneum 3 to 5 days postinfection and measured the numbers of responding peptide-specific T CD8ϩ by IFN-␥-ICS. For B6 mice, PA 224-233 and NP 366-374 represent IDDs (Fig. 1) . PA 224-233 -specific T CD8ϩ are more prevalent than NP 366-374 T CD8ϩ . PA 224-233 -specific T CD8ϩ respond more rapidly and decline sooner. Note the compartment-dependent discrepancy in the responses, which peaks on day 7 when the ratio of peritoneal to splenic PA 224-233 -specific T CD8ϩ is 1:3 versus 1:4 for NP 366-374 -specific T CD8ϩ . This is consistent with either differential presentation of the determinants in the spleen versus the peritoneum or differential regulation of the responding T CD8ϩ , e.g., due to increased immunodomination in the peritoneum by PA 224-233 -specific T CD8ϩ . By contrast, for BALB/c mice (Fig. 2) , the IDD NP 147-155 is more dominant in splenic T CD8ϩ than in peritoneal T CD8ϩ . Again, all specificities in both sites peaked on or around day 7.
Perforin has a minor role in establishing immunodominance hierarchies. Immunodomination is an extensively documented feature of immunodominance in which dominant T CD8ϩ suppress the response of subdominant T CD8ϩ (13, 39, 46) . A possible mechanism of immunodomination is perforinmediated lysis of APCs by dominant T CD8ϩ . To test this possibility, we determined the immunodominance hierarchy in perforin Ϫ/Ϫ B6 (20) and BALB/c mice (1). As seen in Fig. 1 and 2 , T CD8ϩ responses for perforin Ϫ/Ϫ B6 mice differed only slightly from those for wild-type mice. In perforin Ϫ/Ϫ mice on day 7 postinfection, there was an approximate doubling in responses to all determinants except NP 366-374 . This may be due to increased antigenic presentation as a result of increased viral load or reduced lysis of APCs. The failure of NP 366-374 -specific T CD8ϩ to increase may reflect a decrease in its ability to immunodominate other determinants due to a decreased capacity to kill APCs.
By contrast, the number of responding T CD8ϩ did not demonstrate a general increase in BALB/c perforin Ϫ/Ϫ mice. The only significant alteration was a relative increase in the frequency of NP 39-47 -specific T CD8ϩ , which ascended the dominance hierarchy at the expense of HA 518-526 . Since presentation of NP [39] [40] [41] [42] [43] [44] [45] [46] [47] is limiting in vivo (10), this may reflect increased antigen presentation due to decreased lysis of APCs.
Immunodominance hierarchy is intact in T CD4؉ -deficient mice. It has been documented at the population level that naïve T CD8ϩ demonstrate variable requirements for T CD4ϩ -mediated help. T CD4ϩ seem to be particularly important in activation of naïve T CD8ϩ that are activated by cross-priming, i.e., presentation of exogenous antigens by professional APCs (6) . We examined the influence of T CD4ϩ on the immunodominance hierarchy in B6 mice by using mice with targeted deletions of CD4 (23) or I-A b ␤ chain (18). As seen in Fig. 1 , the absence of CD4 resulted in a decrease in the number of responding splenic T CD8ϩ (except NP 366-374 -specific T CD8ϩ , which responded better) but had little effect on the immunodominance hierarchy. In I-A bϪ/Ϫ animals ( Fig. 1 ), responses to NP 366-374 were enhanced for both the spleen and the peritoneum while responses to PA 224-233 were concomitantly reduced. Responses to other subdominant determinants were not significantly altered.
Interference with CD28-B7 interactions has little impact on the immunodominance hierarchy. The interaction of APC B7 with T CD8ϩ CD28 or CD152 (CTLA-4) positively and negatively regulates T CD8ϩ activation, respectively. To examine the role of B7-mediated immune modulation, we treated B6 mice with soluble CD152, which binds to B7 in vivo and interferes with its costimulatory properties (21) . As a control, mice were injected with a mutated version of CD152 which no longer binds B7 (21) . Animals were injected with recombinant proteins for three consecutive days beginning the day prior to infection with IV, and T CD8ϩ responses were measured on day 7. As seen in Fig. 3 , injection with soluble CD152 (but not mutant CD152) greatly diminished T CD8ϩ responses, as previously demonstrated for other viral infections (24) . Notably, the immunodominance hierarchy was not significantly affected among the T CD8ϩ activated under these conditions. To examine the possible influence of B7-CD152 negative regulation, we treated mice with the anti-CD152 MAb UC10-4F10-11 using the same injection schedule. This had no significant effect on the vigor or specificity of T CD8ϩ responses.
These findings indicate that the B7-CD28 interaction greatly enhances anti-IV T CD8ϩ responses but does not favor immunodominant T CD8ϩ . Additionally, negative signaling via CD152 appears to exert little impact on the vigor or nature of the peak T CD8ϩ response. It was therefore of interest to determine whether the immunodominance hierarchies of H-2 b and H-2 d mice are maintained in F 1 animals (Fig. 4) . Responses to most determinants peaked 1 day earlier than in parental mice. The overall number of responding T CD8ϩ was similar in F 1 and parental mice, indicating that increasing the diversity of the response does not result in a net increase in responsiveness. Moreover, the reduction in responses was spread fairly evenly among determinants, such that the hierarchies were more or less melded with each other. This finding, like those above, point to the stability of immunodominance hierarchies. This is not to say that dominance hierarchies are always this predictable: indeed there are examples both old (reviewed in reference 46) and new (2) of scrambling of hierarchies associated with mixing of allomorphs. Rather, the present data provide an example that such reordering of immunodominance hierarchies is not inevitable upon introduction of new restriction elements.
DISCUSSION
As strategies for identifying potential T CD8ϩ gain in sophistication and methods for identifying antigen-specific T CD8ϩ gain in sensitivity, we nudge closer to appreciating immune responses in all their splendid complexity. While not so long ago it was sufficient to characterize T CD8ϩ responses to potential antigens in an all or none manner, it is now clear that responses are composed of swarms of T CD8ϩ clones responding to multiple determinants in predictable hierarchies.
Clearly, two of the important factors in establishing dominance hierarchies in response to different determinants are the efficiency of generating peptide class I complexes and the existence of T CD8ϩ clones capable of responding to the complex. These alone, however, do not fully account for the positions of determinants within the hierarchy. We therefore explored a number of potential contributing factors. Our results obtained with perforin Ϫ/Ϫ mice indicate that perforin-mediated elimination of APCs has a limited role in establishing the anti-IV hierarchy ( Fig. 1 and 2 ). Since perforin-dependent lysis is the primary mechanism used by T CD8ϩ (20, 41) , killing of APCs by immunodominant clones probably does not play a major role in immunodominance in this system, echoing prior findings in the response of mice to Listeria monocytogenes (1) .
A previous study found that the polyclonal pulmonary T CD8ϩ response to intranasal IV infection was reduced in I-A bϪ/Ϫ animals (38) . By contrast, we failed to observe a significant difference in the numbers of responding T CD8ϩ associated with deletion of class II molecules or CD4. This may be related to differences in the virus strains used, the route or dose of infection, or methodologies. We found that the immunodominance hierarchy was largely unaffected by the absence of T CD4ϩ . There was a relatively minor shuffling in the immunodominance hierarchy in I-A bϪ/Ϫ mice, where NP 366-374 -specific T CD8ϩ replace PA 224-233 T CD8ϩ at the top of the hierarchy. Curiously, this was not observed in CD4
Ϫ/Ϫ mice. Rahemtulla have shown that CD4 Ϫ/Ϫ mice maintain functional class II-restricted helper cells in the form of CD8-CD-TCR␣␤ ϩ T cells (28) . Such help is not available in I-A bϪ/Ϫ mice, suggesting that the immunodominance of PA 224-233 requires help normally provided by T CD4ϩ . Notably, even in I-A bϪ/Ϫ mice, PA 224-233 occupies the ␤-position in the immunodominance hierarchy, indicating that the requirement for help is relative rather than absolute.
We confirmed previous findings that CTLA-4-Ig strongly interferes with activation of virus-specific T CD8ϩ in general (24) and IV-specific T CD8ϩ in particular (26) . Notably, FIG. 3 . Effects of interfering with CD28-B7 interaction immunodominance hierarchy in B6 mice. B6 mice were injected once a day for 3 days with 150 to ϳ200 g of ␣-CTLA-4, recombinant CTLA-4.Fc, mutated recombinant CTLA-4.Fc, or phosphate-buffered saline (PBS). Mice were infected with PR8 on the second day of the regimen. As described in Fig. 1 We failed to detect a significant effect of the anti-CD152 MAb UC10-4F10-11 on either the overall ␣-IV T CD8ϩ response or the immunodominance hierarchy. Administration of this antibody under similar conditions has been shown to interfere with the CTLA-4-mediated negative regulation of antitumor and antiself responses (32) . It has been reported that CD152 has a greater influence on deactivating memory T CD8ϩ than naïve T CD8ϩ (9) . In future studies it will be of interest to examine the influence of CD152 on the immunodominance hierarchy in memory T CD8ϩ . Altogether, our findings indicate that while costimulation positively influences the activation of naïve virus-specific T CD8ϩ , it does so in a global manner and does not make a significant contribution to the establishment of immunodominance hierarchies. Rather, hierarchies appear to result from intrinsic properties of the T CD8ϩ repertoire. Using recombinant vaccinia viruses, numerous studies have shown that increasing the number of peptide class I complexes generated from an inserted gene can boost the response to a nominal determinant relative to the response to vaccinia virus gene products (45) . In other words, modifying the relative amounts of peptide class I complexes presented by a given APC can alter the immunodominance hierarchy. The present findings predict that altering the nature of the APC would influence the immunodominance hierarchy only inasmuch as this modifies the relative quantities of the determinants presented by the APC, and not by altering costimulatory signals.
